Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boaz Politi

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Nature Communications|April 16, 2024
Synergistic effect of two human-like monoclonal antibodies confers protection against orthopoxvirus infectionHadas Tamir, Tal Noy-Porat, Sharon Melamed, et al.
Viruses|June 28, 2023
VSV-ΔG-Spike Candidate Vaccine Induces Protective Immunity and Protects K18-hACE2 Mice against SARS-CoV-2 VariantsYfat Yahalom-Ronen, Hadas Tamir, Sharon Melamed, et al.
Nature Communications|October 6, 2021
Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunityHagit Achdout, Einat B Vitner, Boaz Politi, et al.
Frontiers in Bioengineering and Biotechnology|October 18, 2021
Monitoring Group Activity of Hamsters and Mice as a Novel Tool to Evaluate COVID-19 Progression, Convalescence, and rVSV-ΔG-Spike Vaccination EfficacySharon Melamed, Boaz Politi, Ettie Grauer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 12, 2020
Detection and infectivity potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination in isolation units and quarantine facilitiesAmir Ben-Shmuel, Tal Brosh-Nissimov, Itai Glinert, et al.
Nature Communications|February 12, 2021
Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibodyRonit Rosenfeld, Tal Noy-Porat, Adva Mechaly, et al.
Vaccines|February 26, 2022
Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human SeraYfat Yahalom-Ronen, Noam Erez, Morly Fisher, et al.
Archives of Toxicology|May 16, 2022
rVSV-ΔG-SARS-CoV-2-S vaccine: repeated intramuscular (IM) toxicity, local tolerance, immunogenicity and biodistribution study in NZW rabbitsAmir Rosner, Michal Steiner, Sharon Melamed, et al.
Archives of Toxicology|January 15, 2022
Preliminary nonclinical safety and immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigsNoa Madar-Balakirski, Amir Rosner, Sharon Melamed, et al.
JCI Insight|May 11, 2021
Mice with induced pulmonary morbidities display severe lung inflammation and mortality following exposure to SARS-CoV-2Reut Falach, Liat Bar-On, Shlomi Lazar, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Nature Communications|April 16, 2024
Synergistic effect of two human-like monoclonal antibodies confers protection against orthopoxvirus infectionHadas Tamir, Tal Noy-Porat, Sharon Melamed, et al.
Viruses|June 28, 2023
VSV-ΔG-Spike Candidate Vaccine Induces Protective Immunity and Protects K18-hACE2 Mice against SARS-CoV-2 VariantsYfat Yahalom-Ronen, Hadas Tamir, Sharon Melamed, et al.
Nature Communications|October 6, 2021
Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunityHagit Achdout, Einat B Vitner, Boaz Politi, et al.
Frontiers in Bioengineering and Biotechnology|October 18, 2021
Monitoring Group Activity of Hamsters and Mice as a Novel Tool to Evaluate COVID-19 Progression, Convalescence, and rVSV-ΔG-Spike Vaccination EfficacySharon Melamed, Boaz Politi, Ettie Grauer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 12, 2020
Detection and infectivity potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination in isolation units and quarantine facilitiesAmir Ben-Shmuel, Tal Brosh-Nissimov, Itai Glinert, et al.
Nature Communications|February 12, 2021
Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibodyRonit Rosenfeld, Tal Noy-Porat, Adva Mechaly, et al.
Vaccines|February 26, 2022
Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human SeraYfat Yahalom-Ronen, Noam Erez, Morly Fisher, et al.
Archives of Toxicology|May 16, 2022
rVSV-ΔG-SARS-CoV-2-S vaccine: repeated intramuscular (IM) toxicity, local tolerance, immunogenicity and biodistribution study in NZW rabbitsAmir Rosner, Michal Steiner, Sharon Melamed, et al.
Archives of Toxicology|January 15, 2022
Preliminary nonclinical safety and immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigsNoa Madar-Balakirski, Amir Rosner, Sharon Melamed, et al.
JCI Insight|May 11, 2021
Mice with induced pulmonary morbidities display severe lung inflammation and mortality following exposure to SARS-CoV-2Reut Falach, Liat Bar-On, Shlomi Lazar, et al.
Pageof 4